26 October 2021: Clinical Research
Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis
Darius Gleiznys 1ABCDEFG* , Albertas Kriauciunas 1BCDE , Julius Maminskas 1AB , Arturas Stumbras 2FG , Dalia Giedrimiene 3CD , Christine Niekrash 4CDE , Alvydas Gleiznys 1AD , Jurgina Sakalauskiene 1ABEF , Astra Vitkauskiene 5ACDEDOI: 10.12659/MSM.932243
Med Sci Monit 2021; 27:e932243
Table 5 Prognosis bacteria Parvimonas micra by using logistic regression method according to TNF-α in peri-implant crevicular fluid of the mucositis patients untreated group.
| Parvimonas micra | TNF-α, median [25–75%], mean rank | Area under the ROC curve, % | Optimal cut-off value of TNF-α | Sensitivity/ specificity, % | Parvimonas micra, n (%) | OR [95% CI] |
|---|---|---|---|---|---|---|
| No | 2.75 [2.34–3.31], 11.33 | 73.1 | 88.9/58.3 | 5 (41.7) | 1.0 | |
| Yes | 3.61 [2.99–3.84], 18.26 | 16 (88.9) | 11.2 [1.735–72.3] | |||
| value | 0.034* | 0.006** | ||||
| ROC – receiver pperating characteristics; OR – odds ratio; CI – confidence interval; * value by Mann-Whitney test; ** asymptotic P value. | ||||||